Dispersing tablets against cervicitis
A technology for anti-uterine inflammation and dispersible tablets, which is applied in the direction of medical preparations containing active ingredients, plant/algae/fungus/moss components, plant raw materials, etc., and can solve the negative effects of adhesion, difficult industrialization, drug disintegration and dissolution and other problems, to achieve the effect of improving disintegration and large room for maneuver
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0053] The traditional Chinese medicine raw materials of Kanggongyan Dispersible Tablets: 167g of Guangdong Zizhu dry extract, 44g of motherwort dry extract, and 39g of Wuyao dry extract.
[0054] The weight percentage of traditional Chinese medicine extract and auxiliary materials of Kanggongyan Dispersible Tablets: 26% of fine powder of Kanggongyan extract, 20% of pregelatinized starch, 30% of microcrystalline cellulose, 8% of low-substituted hydroxypropyl cellulose, Mannitol 10%, polyvinylpyrrolidone 4%, micronized silica gel 1%, magnesium stearate 1%.
[0055] Kanggongyan Dispersible Tablets are obtained according to the following specific steps: take Guangdong Zizhu, moisten thoroughly, cut into small pieces or original pieces, add water and decoct twice, the first time for 3 hours, the second time for 2 hours, combine the decoction, filter After drying, the filtrate was concentrated to a thick paste, and dried under reduced pressure to obtain Guangdong Zizhu dry extract;...
Embodiment 2
[0058] 38% by weight of fine powder of anti-uterine extract, 20% sodium carboxymethylcellulose, 15% cross-linked polyvinylpyrrolidone, 8% microcrystalline cellulose, 5% polyvinylpyrrolidone, 7% lactose, polyethylene Pyrrolidone 4%, micronized silica gel 1%, magnesium lauryl sulfate 2%. All the other are with embodiment 1.
Embodiment 3
[0060] 32% by weight of fine powder of anti-uterine extract, 21% sodium carboxymethyl starch, 18% croscarmellose sodium, 9% low-substituted hydroxypropyl cellulose, 3% cross-linked polyvinylpyrrolidone , mannitol 6%, polyvinylpyrrolidone 7%, micronized silica gel 2%, magnesium stearate 1%, HLB=15-16 sucrose fatty acid ester 1%. Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, all the other are the same as embodiment 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com